Oslo Garred

412 total citations
10 papers, 314 citations indexed

About

Oslo Garred is a scholar working on Molecular Biology, Endocrinology and Immunology. According to data from OpenAlex, Oslo Garred has authored 10 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Endocrinology and 4 papers in Immunology. Recurrent topics in Oslo Garred's work include Escherichia coli research studies (4 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Transgenic Plants and Applications (2 papers). Oslo Garred is often cited by papers focused on Escherichia coli research studies (4 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Transgenic Plants and Applications (2 papers). Oslo Garred collaborates with scholars based in Norway, Denmark and Switzerland. Oslo Garred's co-authors include Kirsten Sandvig, Bo van Deurs, Elke K. H. Schweda, Pernille Holm, Gerrit van Meer, Ardy van Helvoort, Sjur Olsnes, Markus Lanzrein, Kristine Kleivi Sahlberg and Nina Iversen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

Oslo Garred

8 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oslo Garred Norway 6 144 111 101 96 46 10 314
Samir Taga France 8 208 1.4× 164 1.5× 201 2.0× 36 0.4× 103 2.2× 9 462
Yaobin Liu United States 11 364 2.5× 188 1.7× 125 1.2× 54 0.6× 16 0.3× 15 614
Corinne Capoulade France 7 195 1.4× 44 0.4× 76 0.8× 20 0.2× 33 0.7× 8 341
Sabrina B. Taner United Kingdom 6 133 0.9× 19 0.2× 161 1.6× 86 0.9× 6 0.1× 6 314
Jaime López-Mosqueda United States 7 490 3.4× 53 0.5× 140 1.4× 113 1.2× 10 0.2× 9 564
Maria Luisa Fiani Italy 12 179 1.2× 9 0.1× 159 1.6× 57 0.6× 26 0.6× 22 343
Eileen M. McGuffie United States 11 332 2.3× 62 0.6× 64 0.6× 27 0.3× 33 0.7× 11 468
Timurs Maculins United Kingdom 8 450 3.1× 20 0.2× 80 0.8× 112 1.2× 17 0.4× 8 527
Katharina Hötte Germany 7 238 1.7× 14 0.1× 93 0.9× 34 0.4× 13 0.3× 8 420
Hyunmin Kim South Korea 12 518 3.6× 89 0.8× 52 0.5× 39 0.4× 7 0.2× 22 646

Countries citing papers authored by Oslo Garred

Since Specialization
Citations

This map shows the geographic impact of Oslo Garred's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oslo Garred with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oslo Garred more than expected).

Fields of papers citing papers by Oslo Garred

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oslo Garred. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oslo Garred. The network helps show where Oslo Garred may publish in the future.

Co-authorship network of co-authors of Oslo Garred

This figure shows the co-authorship network connecting the top 25 collaborators of Oslo Garred. A scholar is included among the top collaborators of Oslo Garred based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oslo Garred. Oslo Garred is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Faber, Richard, et al.. (2023). Retinocytoma Undergoing Retinoblastoma Transformation in an Adult Patient. SHILAP Revista de lepidopterología. 2023. 1–4.
2.
Haugen, Mads H., Ole Christian Lingjærde, Oslo Garred, et al.. (2019). Design of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients. Annals of Oncology. 30. iii8–iii8.
3.
Garred, Oslo, Elin Borgen, Ellen Schlichting, et al.. (2018). Subtype‐specific clinical and prognostic relevance of tumor‐expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study. Journal of Thrombosis and Haemostasis. 16(7). 1347–1356. 18 indexed citations
4.
Garred, Oslo, et al.. (2018). Coagulation factor V is expressed in tumors and predicts favorable outcome in aggressive breast cancer. Thrombosis Research. 164. S183–S183. 3 indexed citations
5.
Sandvig, Kirsten, Oslo Garred, & Bo van Deurs. (1997). Intracellular Transport and Processing of Protein Toxins Produced by Enteric Bacteria. Advances in experimental medicine and biology. 412. 225–232. 12 indexed citations
6.
Garred, Oslo, et al.. (1997). [Self-inhibiting N-glycosidase activity of shigella toxin].. PubMed. 31(3). 528–35. 2 indexed citations
7.
Sandvig, Kirsten, Oslo Garred, Ardy van Helvoort, Gerrit van Meer, & Bo van Deurs. (1996). Importance of glycolipid synthesis for butyric acid-induced sensitization to shiga toxin and intracellular sorting of toxin in A431 cells.. Molecular Biology of the Cell. 7(9). 1391–1404. 59 indexed citations
8.
Sandvig, Kirsten, Oslo Garred, & Bo van Deurs. (1996). Thapsigargin-induced transport of cholera toxin to the endoplasmic reticulum.. Proceedings of the National Academy of Sciences. 93(22). 12339–12343. 33 indexed citations
10.
Sandvig, Kirsten, et al.. (1994). Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.. The Journal of Cell Biology. 126(1). 53–64. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026